Daniela Neri

Dr. Daniela Neri


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2019 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
DNDaniela Neri
Daniela Neri
EMEuridice Martinez‐Steele
Euridice Martinez‐Steele
CMCarlos Augusto Monteiro
Carlos Augusto Monteiro
RLRenata Bertazzi Levy
Renata Bertazzi Levy

1 January 2003 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
HCHugo Costa-Ribeiro
Hugo Costa-Ribeiro
TRTereza Cristina M. Ribeiro
Tereza Cristina M. Ribeiro
AMAngela P. Mattos
Angela P. Mattos
SVSandra S. Valois
Sandra S. Valois
DNDaniela Neri
Daniela Neri
JVJon A. Vanderhoof
Jon A. Vanderhoof

30 August 2012 in Current HIV/AIDS Reports
Verified
Journal Article
Closed access
PDF file
DBDiana Botros
Diana Botros
GSGabriel Somarriba
Gabriel Somarriba
DNDaniela Neri
Daniela Neri
TMTracie L. Miller
Tracie L. Miller

2 April 2019 in Maternal & Child Nutrition
Verified
Journal Article
Closed access
PDF file
RMRenata Mariana Martines
Renata Mariana Martines
PMPriscila Machado
Priscila Machado
DNDaniela Neri
Daniela Neri
RLRenata Bertazzi Levy
Renata Bertazzi Levy
FRFernanda Rauber
Fernanda Rauber

17 January 2022 in Journal of the Academy of Nutrition and Dietetics
Verified
Journal Article
Closed access
DNDaniela Neri
Daniela Neri
ESEuridice Martinez Steele
Euridice Martinez Steele
NKNeha Khandpur
Neha Khandpur
RLRenata Levy
Renata Levy

1 October 2010 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
TMTracie L Miller
Tracie L Miller
GSGabriel Somarriba
Gabriel Somarriba
EOE John Orav
E John Orav
AMArmando J Mendez
Armando J Mendez
DNDaniela Neri
Daniela Neri
SLSteven E Lipshultz
Steven E Lipshultz
Background: We compared biomarkers of vascular dysfunction among HIV-infected children to a demographically similar group of uninfected children and determined factors associated with these biomarkers. Methods and Results: We measured several biomarkers of vascular dysfunction: C-reactive protein (CRP), interleukin-6 (IL-6), and monocyte chemoattractant protein −1 (MCP-1) (inflammation); fibrinogen and P-selectin (coagulant dysfunction); soluble intracellular cell adhesion molecule-1 (sICAM), soluble vascular cell adhesion molecule-1 (sVCAM), and E-selectin (endothelial dysfunction); and leptin (metabolic dysfunction). Anthropometry, body composition, CD4%, HIV viral load, and antiretroviral therapy were recorded. Mean age was 14.8 years (106 HIV-infected children) and 12.3 years (55 control children). Sex and body mass index Z scores were similar. Infected children had higher sICAM, sVCAM, MCP-1, IL-6, and fibrinogen levels. E-selectin (P = 0.07), and CRP (P = 0.08) trended to be greater in the HIV group, yet leptin and P-selectin were similar. In multivariable analyses in the HIV-infected children alone, each 1 standard deviation increase in waist to hip ratio was associated with increases in sICAM (17%), MCP-1 (19%), IL6 (18%), and CRP (59%). CD4% was inversely associated with sVCAM, MCP-1, IL6, fibrinogen, and CRP. Conclusions: HIV-infected children have higher levels of biomarkers of vascular dysfunction than healthy children. Risk factors associated with these biomarkers include higher waist to hip ratios and HIV disease severity.